Early-onset Parkinson disease

Gene: SLC16A2

Green List (high evidence)

SLC16A2 (solute carrier family 16 member 2, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000147100
EnsemblGeneIds (GRCh37): ENSG00000147100
OMIM: 300095, ClinGen, DECIPHER
SLC16A2 is in 17 panels

1 review

Bryony Thompson (Royal Melbourne Hospital)

Green List (high evidence)

PMID 40088079 reports 11 male patients from 11 families with hemizygous SLC16A2 loss-of-function variants; five independent families carry qualifying frameshift or splice null alleles causing Allan‑Herndon‑Dudley syndrome with childhood parkinsonism (hypokinesia, rigidity, dystonia, autonomic dysfunction). CSF homovanillic acid is markedly reduced and six treated families improve with levodopa/carbidopa. PMID 41144879 describes ten additional male patients with genetically confirmed SLC16A2 deficiency and infantile parkinsonism but provides no variant details, preventing independent family counting. The childhood parkinsonism phenotype aligns with the Early‑onset Parkinson disease panel's focus on abnormal extrapyramidal motor function.
Sources: Literature
Created: 20 Jun 2026, 6:41 p.m.

Mode of inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)

Phenotypes
Allan-Herndon-Dudley syndrome, MONDO:0010354

Publications

Details

Mode of Inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Sources
  • Expert Review Green
  • Literature
Phenotypes
  • Allan-Herndon-Dudley syndrome, MONDO:0010354
OMIM
300095
ClinGen
SLC16A2
DECIPHER
SLC16A2
Clinvar variants
Variants in SLC16A2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
20 Jun 2026, Gel status: 3

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: slc16a2 has been classified as Green List (High Evidence).

20 Jun 2026, Gel status: 3

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: slc16a2 has been classified as Green List (High Evidence).

20 Jun 2026, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

gene: SLC16A2 was added gene: SLC16A2 was added to Early-onset Parkinson disease. Sources: Literature Mode of inheritance for gene: SLC16A2 was set to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males) Publications for gene: SLC16A2 were set to 41144879; 40088079 Phenotypes for gene: SLC16A2 were set to Allan-Herndon-Dudley syndrome, MONDO:0010354 Review for gene: SLC16A2 was set to GREEN